Category: $7.2B

  • Jazz to Acquire GW Pharmaceuticals for $7.2B

    Shots: Jazz to acquire GW Pharmaceuticals for $220/ GW ADS, out of which $200 in cash and $20 in Jazz ordinary shares, making a total deal value $7.2B with a 50% premium over a GW’s closing stock price on Feb 2, 2021. The transaction expected to close in Q2’21 The acquisition will expand Jazz’ neuroscience […]